JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

Workday (NASDAQ:WDAY – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities raised the firm’s price target on Cloudflare (NET) to $180 from $135 and keeps an Outperform rating on the shares. Cloudflare ...

Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

Wall Street analysts rerated Cloudflare, Inc (NYSE:NET) after the company released its fourth-quarterly print Thursday.

In this article, we are going to take a look at where Cloudflare, Inc. (NYSE:NET) stands against the other AI stocks. AI is ...

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where CyberArk Software Ltd. (NASDAQ:CYBR) stands against the other AI stocks.

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...